Drugs / cotinine
cotinine
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00879918 | Dec 2008 → Mar 2012 | — | University of California, San Francisco | Completed | No outcome recorded |
| Phase 1 | NCT00994591 | Jan 2007 → Jun 2011 | — | University of California, San Francisco | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT00000296 | Nov 1997 → Dec 2001 | nicotine dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 2 | NCT00000288 | Dec 1995 → Dec 2002 | nicotine dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 2 | NCT00000284 | Feb 1995 → Dec 2001 | nicotine dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cotinine | “Pharmacokinetic testing involves dosing with deuterated cotinine which has an associated IND#61329.” NCT00994591 ↗ |
| Known as | Cotinina | ChEMBL registry synonym — accepted as the source's own label CHEMBL578211 ↗ |
| Known as | COTININE FUMARATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL578211 ↗ |
| Known as | Nicotine related compound c | ChEMBL registry synonym — accepted as the source's own label CHEMBL578211 ↗ |
| Modality | Small molecule | — CHEMBL578211 ↗ |
| Route | Intravenous | “after IV dosing” NCT00879918 ↗ |